Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters

Obesity Surgery

Volumn 22, Issue 1, 2012, Pages 62-69

  Janković, Draženka ^a   Wolf, Peter ^a   Anderwald, Christian Heinz ^a,b   Winhofer, Yvonne ^a   Promintzer Schifferl, Miriam ^a   Hofer, Astrid ^a   Langer, Felix ^a   Prager, Gerhard ^a   Ludvik, Bernhard ^a   Gessl, Alois ^a   Luger, Anton ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

Author keywords

Bariatric surgery; Cushing's syndrome; Glucose tolerance; Insulin resistance; Morbid obesity; Thyroid function

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; INSULIN; THYROTROPIN;

ADULT; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; CONTROLLED STUDY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTHYROIDISM; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AUSTRIA; BARIATRIC SURGERY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES; THYROTROPIN; WEIGHT LOSS;

EID: 84857359236     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0545-4     Document Type: Article

References (48)

1. P Kokkoris FX Pi-Sunyer 2003 Obesity and endocrine disease Endocrinol Metab Clin North Am 32 895 914 14711067 10.1016/S0889-8529(03)00078-1 1:CAS:528:DC%2BD2cXmsVSitQ%3D%3D (Pubitemid 38029986)
2. GL Maddox V Liederman 1969 Overweight as a social disability with medical implications J Med Educ 44 214 20 5774591 1:STN:280:DyaF1M7js1Ortw%3D%3D
3. JH Price SM Desmond RA Krol, et al. 1987 Family practice physicians' beliefs, attitudes, and practices regarding obesity Am J Prev Med 3 339 45 3452374 1:STN:280:DyaL1c3ltFOrsA%3D%3D (Pubitemid 18018424)
4. MA Michalaki AG Vagenakis AS Leonardou, et al. 2006 Thyroid function in humans with morbid obesity Thyroid 16 73 8 16487017 10.1089/thy.2006.16.73 1:CAS:528:DC%2BD28XhsFOrtLg%3D (Pubitemid 43348719)
5. R Sari MK Balci H Altunbas, et al. 2003 The effect of body weight and weight loss on thyroid volume and function in obese women Clin Endocrinol (Oxf) 59 258 62 10.1046/j.1365-2265.2003.01836.x (Pubitemid 36918663)
6. Y Raftopoulos DJ Gagne P Papasavas, et al. 2004 Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity Obes Surg 14 509 13 15130228 10.1381/096089204323013514 (Pubitemid 38570291)
7. R Fazylov E Soto S Cohen, et al. 2008 Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism Obes Surg 18 644 7 18368462 10.1007/s11695-007-9279-8
8. S Alagna ML Cossu A Masala, et al. 2003 Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery Eat Weight Disord 8 95 9 12880185 1:STN:280:DC%2BD3szkslOlsA%3D%3D
9. S Buscemi S Verga R Maneri, et al. 1997 Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass J Endocrinol Invest 20 276 81 9258807 1:STN:280:DyaK2svgtlCgug%3D%3D (Pubitemid 27338845)
10. B Catargi V Rigalleau A Poussin, et al. 2003 Occult Cushing's syndrome in type-2 diabetes J Clin Endocrinol Metab 88 5808 13 14671173 10.1210/jc.2003-030254 1:CAS:528:DC%2BD3sXhtVSgsr3P (Pubitemid 38033055)
11. M Omura J Saito K Yamaguchi, et al. 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan Hypertens Res 27 193 202 15080378 10.1291/hypres.27.193 (Pubitemid 38489081)
12. GH Anderson Jr N Blakeman DH Streeten 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients J Hypertens 12 609 15 7930562 10.1097/00004872-199405000-00015 (Pubitemid 24192887)
13. O Tiryakioglu S Ugurlu S Yalin, et al. 2010 Screening for Cushing's syndrome in obese patients Clinics (Sao Paulo) 65 9 13 10.1590/S1807- 59322010000100003
14. C Anderwald M Anderwald-Stadler M Promintzer, et al. 2007 The Clamp-like index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects Diabetes Care 30 2374 80 17595351 10.2337/dc07-0422 1:CAS:528:DC%2BD2sXhtV2mu7vK (Pubitemid 47359049)
15. M Promintzer M Krebs J Todoric, et al. 2007 Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor J Clin Endocrinol Metab 92 4306 12 17726077 10.1210/jc.2006-2522 1:CAS:528: DC%2BD2sXhtlartbrP (Pubitemid 350074749)
16. Chiodini I. Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011.
17. T Nickelsen W Lissner K Schoffling 1989 The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test Exp Clin Endocrinol 94 275 80 2560985 10.1055/s-0029-1210910 1:CAS:528:DyaK3cXhsFajsro%3D (Pubitemid 20072269)
18. AC Qureshi A Bahri LA Breen, et al. 2007 The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol Clin Endocrinol (Oxf) 66 632 5 10.1111/j.1365-2265.2007.02784.x 1:CAS:528:DC%2BD2sXlvFKluro%3D (Pubitemid 46699528)
19. LK Nieman BM Biller JW Findling, et al. 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 93 1526 40 18334580 10.1210/jc.2008-0125 1:CAS:528:DC%2BD1cXlvFWhu78%3D (Pubitemid 351656485)
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
21. SK Baid D Rubino N Sinaii, et al. 2009 Specificity of screening tests for Cushing's syndrome in an overweight and obese population J Clin Endocrinol Metab 94 3857 64 19602562 10.1210/jc.2008-2766 1:CAS:528:DC%2BD1MXht12ru7nO
22. DS Cooper 2001 Clinical practice. Subclinical hypothyroidism N Engl J Med 345 260 5 11474665 10.1056/NEJM200107263450406 1:STN:280:DC%2BD3MvisF2htg%3D%3D (Pubitemid 32695067)
23. L Douyon DE Schteingart 2002 Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion Endocrinol Metab Clin North Am 31 173 89 12055988 10.1016/S0889-8529(01)00023-8 1:CAS:528:DC%2BD38XkvFensb0%3D (Pubitemid 34578620)
24. H al-Adsani LJ Hoffer JE Silva 1997 Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement J Clin Endocrinol Metab 82 1118 25 9100583 10.1210/jc.82.4.1118 1:CAS:528:DyaK2sXitlOiu7k%3D (Pubitemid 27166652)
25. A Sorisky A Bell A Gagnon 2000 TSH receptor in adipose cells Horm Metab Res 32 468 74 11246811 10.1055/s-2007-978672 1:CAS:528:DC%2BD3MXisFSqt7c%3D (Pubitemid 32176073)
26. RW Valyasevi DA Harteneck CM Dutton, et al. 2002 Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts J Clin Endocrinol Metab 87 2352 8 11994387 10.1210/jc.87.5.2352 1:CAS:528:DC%2BD38XjsFGgsrg%3D (Pubitemid 34521530)
27. F Guo K Bakal Y Minokoshi, et al. 2004 Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo Endocrinology 145 2221 7 14764630 10.1210/en.2003-1312 1:CAS:528:DC%2BD2cXjsVyqu7c%3D (Pubitemid 38535051)
28. P Kok F Roelfsema JG Langendonk, et al. 2005 High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction J Clin Endocrinol Metab 90 4659 63 15914521 10.1210/jc.2005-0920 1:CAS:528:DC%2BD2MXnvVWlu78%3D (Pubitemid 41159356)
29. Moulin de Moraes CM MC Mancini ME de Melo, et al. 2005 Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass Obes Surg 15 1287 91 10.1381/096089205774512537 (Pubitemid 41565128)
30. T Reinehr 2010 Obesity and thyroid function Mol Cell Endocrinol 316 165 71 19540303 10.1016/j.mce.2009.06.005 1:CAS:528:DC%2BD1MXhs1WgtbnL
31. PM Stewart A Boulton S Kumar, et al. 1999 Cortisol metabolism in human obesity: impaired cortisone- > cortisol conversion in subjects with central adiposity J Clin Endocrinol Metab 84 1022 7 10084590 10.1210/jc.84.3.1022 1:CAS:528:DyaK1MXhvFegu7Y%3D (Pubitemid 29138237)
32. A Hautanen K Raikkonen H Adlercreutz 1997 Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males J Intern Med 241 451 61 10497620 10.1111/j.1365-2796.1997.tb00002.x 1:STN:280:DyaK1Mvislaksg%3D%3D (Pubitemid 27315825)
33. M Manco JM Fernandez-Real ME Valera-Mora, et al. 2007 Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care 30 1494 500 17526821 10.2337/dc06-1353 1:CAS:528:DC%2BD2sXntlWktrw%3D (Pubitemid 46871160)
34. C Lambillotte P Gilon JC Henquin 1997 Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets J Clin Invest 99 414 23 9022074 10.1172/JCI119175 1:CAS:528:DyaK2sXhtVKksbs%3D (Pubitemid 27414798)
35. B Mariniello V Ronconi S Rilli, et al. 2006 Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome Eur J Endocrinol 155 435 41 16914598 10.1530/eje.1.02228 1:CAS:528:DC%2BD28XhtVClur%2FE (Pubitemid 44463950)
36. R Desbriere V Vuaroqueaux V Achard, et al. 2006 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients Obesity (Silver Spring) 14 794 8 10.1038/oby.2006.92 1:CAS:528:DC%2BD28XotlKlu7Y%3D (Pubitemid 46219720)
37. ML Ricketts JM Verhaeg I Bujalska, et al. 1998 Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues J Clin Endocrinol Metab 83 1325 35 9543163 10.1210/jc.83.4.1325 1:CAS:528:DyaK1cXitlyntLc%3D (Pubitemid 28496416)
38. L Freeman M Hewison SV Hughes, et al. 2005 Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells Blood 106 2042 9 15941907 10.1182/blood-2005-01-0186 1:CAS:528:DC%2BD2MXhtVWksLrP (Pubitemid 41291718)
39. R Munoz C Carvajal A Escalona, et al. 2009 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients Obes Surg 19 764 70 18592327 10.1007/s11695-008-9616-6
40. P Anagnostis VG Athyros K Tziomalos, et al. 2009 Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis J Clin Endocrinol Metab 94 2692 701 19470627 10.1210/jc.2009-0370 1:CAS:528: DC%2BD1MXpvFGnsbo%3D
41. AM Ward CH Fall CE Stein, et al. 2003 Cortisol and the metabolic syndrome in South Asians Clin Endocrinol (Oxf) 58 500 5 10.1046/j.1365-2265.2003.01750.x 1:CAS:528:DC%2BD3sXjsFylsLk%3D (Pubitemid 36390623)
42. N Ravaja L Keltikangas-Jarvinen J Viikari 1996 Life changes, locus of control and metabolic syndrome precursors in adolescents and young adults: a three-year follow-up Soc Sci Med 43 51 61 8816010 10.1016/0277-9536(95)00333-9 1:STN:280:DyaK28vht1Klsw%3D%3D (Pubitemid 26190870)
43. AD Karelis M Brochu R Rabasa-Lhoret 2004 Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 30 569 72 15671927 10.1016/S1262-3636(07)70156-8 1:STN:280:DC%2BD2M%2FktlagsA%3D%3D (Pubitemid 40070359)
44. AD Karelis M Faraj JP Bastard, et al. 2005 The metabolically healthy but obese individual presents a favorable inflammation profile J Clin Endocrinol Metab 90 4145 50 15855252 10.1210/jc.2005-0482 1:CAS:528:DC%2BD2MXmtlCitbY%3D (Pubitemid 41058189)
45. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2010.
46. E Bonora S Kiechl J Willeit, et al. 1998 Prevalence of insulin resistance in metabolic disorders: the Bruneck Study Diabetes 47 1643 9 9753305 10.2337/diabetes.47.10.1643 1:CAS:528:DyaK1cXmtlSmtLw%3D (Pubitemid 28445355)
47. E Ferrannini A Natali P Bell, et al. 1997 Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR) J Clin Invest 100 1166 73 9303923 10.1172/JCI119628 1:CAS:528: DyaK2sXlvFOgsLc%3D
48. RP Wildman P Muntner K Reynolds, et al. 2008 The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch Intern Med 168 1617 24 18695075 10.1001/archinte.168.15.1617